Nalaganje...
Efficacy and Safety of a Single Dose of Ivermectin, Diethylcarbamazine, and Albendazole for Treatment of Lymphatic Filariasis in Côte d’Ivoire: An Open-label Randomized Controlled Trial
BACKGROUND: Improved drug regimens are needed to accelerate elimination of lymphatic filariasis in Africa. This study determined whether a single co-administered dose of ivermectin plus diethylcarbamazine plus albendazole [IDA] is noninferior to standard 3 annual doses of ivermectin plus albendazole...
Shranjeno v:
| izdano v: | Clin Infect Dis |
|---|---|
| Main Authors: | , , , , , , , , |
| Format: | Artigo |
| Jezik: | Inglês |
| Izdano: |
Oxford University Press
2019
|
| Teme: | |
| Online dostop: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7583415/ https://ncbi.nlm.nih.gov/pubmed/31641754 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/cid/ciz1050 |
| Oznake: |
Označite
Brez oznak, prvi označite!
|